Matthew Seldin Lasky

I'll research this attorney's professional background before drafting.

Initial searches surfaced other similarly-named attorneys. Let me dig deeper.

Identity caveat (important): I could not verify an attorney named "Matthew Seldin Lasky" in any published source. The single tracked appearance appears to conflate two attorneys of record for JPMorgan Chase in the same matter — Matthew Seldin Dontzin (Dontzin Nagy & Fleissig LLP) and Benjamin Adam Lasky (Kirkland & Ellis LLP), both listed as counsel for JPMorgan Chase & Co. by VitalLaw. The Kirkland patent-litigation partner whose name is closest to the tracked entry is Benjamin A. Lasky; the practice description below reflects the verified Kirkland record, and should be treated as provisional pending confirmation of the correct individual.

Specialty / focus. On the one tracked matter, Intellectual Ventures II LLC v. JPMorgan Chase & Co., No. 1:13-cv-03777 (S.D.N.Y., filed June 4, 2013), the asserted portfolio included U.S. Patent 6,314,409, which concerns controlling access to and distribution of digital property (DRM/content-protection technology), alongside other software and business-method patents asserted against banking and payment-processing entities. The practice profile that matches the Kirkland-side counsel is broad patent litigation — small-molecule pharmaceuticals and biologics (Hatch-Waxman and BPCIA), medical devices, software and encryption, telecommunications, optics, storage media and DRM — with substantial PTAB work.

Side preference. Tracked data shows 0 plaintiff-side and 1 defendant-side appearance, and the case itself fits that pattern: an operating company (JPMorgan Chase and its bank/payment affiliates) defending against an assertion entity (Intellectual Ventures II). There is no verified record of plaintiff-side or NPE/PAE representation.

Firm context. Kirkland & Ellis (New York), Intellectual Property Group. No prior firms are verified for the "Matthew Seldin Lasky" name. If the intended individual is Benjamin A. Lasky, he joined Kirkland from Freehills (now Herbert Smith Freehills) in Australia; he is not in-house.

Notable case results and PTAB activity. In the JPMorgan matter, the defense won partial summary judgment of patent ineligibility under § 101 (reported May 2015) invalidating three Intellectual Ventures patents. The related interlocutory appeal produced Intellectual Ventures II LLC v. JPMorgan Chase & Co., 781 F.3d 1372 (Fed. Cir. 2015), addressing Federal Circuit jurisdiction over appeals from covered-business-method review institution decisions, and the litigation ended with a Rule 36 affirmance in Fed. Cir. No. 17-2429 (Dec. 17, 2018), where Kirkland's Brent P. Ray argued for the appellees. A parallel CBM petition (CBM2014-00157) was filed against the '409 patent; note the IPRs on that patent (IPR2014-00673, IPR2015-01323) were brought by IBM, not JPMorgan, so they should not be attributed to this attorney.

Bar / education. Not reliably sourced for "Matthew Seldin Lasky." For Benjamin A. Lasky: admitted New York (2006); LL.B., University of New South Wales (2001) and B.Sc. in Genetics; admitted in the S.D.N.Y., E.D.N.Y., E.D. Mich. and the Federal Circuit.